Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Levorphanol Tartrate Anhydrous
2. Levorphan Tartrate
3. Levorphanol Bitartrate
4. Wcb1i20f1k
5. 125-72-4
6. D-(-)-levorphanol Tartrate
7. Morphinan-3-ol, 17-methyl-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) (salt)
8. L-3-hydroxy-n-methylmorphinan Tartrate
9. Ro 1-5431/7
10. Levorphanol Hydrogen Tartrate
11. Nih 4590
12. Einecs 204-753-8
13. Nsc 91012
14. Unii-wcb1i20f1k
15. Nsc-91012
16. Levorphanol L-tartrate
17. Morphinan-3-ol, 17-methyl-, Tartrate (1:1) (salt), (-)-
18. Morphinan-6-ol, N-methyl-, Tartrate (1:1) (salt), Stereoisomer
19. 2h-10,4a-iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, Tartrate
20. Schembl4336924
21. Dtxsid30924987
22. Pdsp2_001546
23. Levorphanol Tartrate [who-dd]
24. Morphinan-3-ol, 17-methyl-, (2r,3r)-2,3-dihydroxybutanedioate (1:1)
25. Q27292556
26. 17-methylmorphinan-3-ol, Tartrate (1:1) (salt)
27. 17-methylmorphinan-3-ol (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)
Molecular Weight | 407.5 g/mol |
---|---|
Molecular Formula | C21H29NO7 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 3 |
Exact Mass | 407.19440226 g/mol |
Monoisotopic Mass | 407.19440226 g/mol |
Topological Polar Surface Area | 139 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 491 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Levorphanol tartrate |
Drug Label | Levo-Dromoran (levorphanol tartrate) is a potent opioid analgesic with empirical formula C17H23NOC4H6O62H2O and molecular weight 443.5. Each mg of levorphanol tartrate is equivalent to 0.58 mg levorphanol base. Chemically levorphanol is levo-3-... |
Active Ingredient | Levorphanol tartrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg |
Market Status | Prescription |
Company | Roxane |
2 of 2 | |
---|---|
Drug Name | Levorphanol tartrate |
Drug Label | Levo-Dromoran (levorphanol tartrate) is a potent opioid analgesic with empirical formula C17H23NOC4H6O62H2O and molecular weight 443.5. Each mg of levorphanol tartrate is equivalent to 0.58 mg levorphanol base. Chemically levorphanol is levo-3-... |
Active Ingredient | Levorphanol tartrate |
Dosage Form | Tablet |
Route | Oral |
Strength | 2mg |
Market Status | Prescription |
Company | Roxane |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
22
PharmaCompass offers a list of Levorphanol Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levorphanol Tartrate manufacturer or Levorphanol Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levorphanol Tartrate manufacturer or Levorphanol Tartrate supplier.
PharmaCompass also assists you with knowing the Levorphanol Tartrate API Price utilized in the formulation of products. Levorphanol Tartrate API Price is not always fixed or binding as the Levorphanol Tartrate Price is obtained through a variety of data sources. The Levorphanol Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Antalgin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antalgin, including repackagers and relabelers. The FDA regulates Antalgin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antalgin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antalgin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antalgin supplier is an individual or a company that provides Antalgin active pharmaceutical ingredient (API) or Antalgin finished formulations upon request. The Antalgin suppliers may include Antalgin API manufacturers, exporters, distributors and traders.
click here to find a list of Antalgin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Antalgin DMF (Drug Master File) is a document detailing the whole manufacturing process of Antalgin active pharmaceutical ingredient (API) in detail. Different forms of Antalgin DMFs exist exist since differing nations have different regulations, such as Antalgin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Antalgin DMF submitted to regulatory agencies in the US is known as a USDMF. Antalgin USDMF includes data on Antalgin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Antalgin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Antalgin suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Antalgin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Antalgin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Antalgin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Antalgin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Antalgin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Antalgin suppliers with NDC on PharmaCompass.
Antalgin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Antalgin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Antalgin GMP manufacturer or Antalgin GMP API supplier for your needs.
A Antalgin CoA (Certificate of Analysis) is a formal document that attests to Antalgin's compliance with Antalgin specifications and serves as a tool for batch-level quality control.
Antalgin CoA mostly includes findings from lab analyses of a specific batch. For each Antalgin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Antalgin may be tested according to a variety of international standards, such as European Pharmacopoeia (Antalgin EP), Antalgin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Antalgin USP).